Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.00%||71.77||1.0%||$472.12m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.00%||615.24||2.7%||$388.21m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.00%||234.06||1.9%||$331.63m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||3.17||0.7%||$221.59m|
|EXAS||EXACT Sciences Corp.||0.00%||78.43||17.9%||$151.61m|
|ALNY||Alnylam Pharmaceuticals, Inc.||0.00%||148.50||8.2%||$151.18m|
|ARNA||Arena Pharmaceuticals, Inc.||0.00%||92.65||13.7%||$144.29m|
|BBIO||BridgeBio Pharma, Inc.||0.00%||12.75||0.0%||$115.66m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.